Reps. Doug Collins (R-Ga.) and Dave Loebsack (D-Iowa) have introduced H.R. 1316, the Prescription Drug Price Transparency Act. The bill’s other original sponsors are Reps. Brian Babin (R-Texas), Rod Blum (R-Iowa), Buddy Carter (R-Ga.), John Duncan, Jr. (R-Tenn.), Cathy McMorris Rodgers (R-Wash.), and John Sarbanes (D-Md.).
The bill would:
Require pharmacy benefit managers (PBMs), which serve TRICARE and the Federal Employee Health Benefits (FEHB) programs, to provide the same updates and disclosures to pharmacies for the maximum allowable costs (MAC) lists that are currently provided to pharmacies in Medicare Part D. These "MAC" lists determine generic reimbursements for pharmacies;
Set a standard for how frequently those lists are updated;
Prohibit sharing patient information with PBM-owned pharmacies (mail order and/or retail) unless a patient has chosen to fill that prescription there, and
Forbid PBMs from mandating patients use their affiliated pharmacies.
The National Community Pharmacists Association has announced strong support for the bill.
Print Page
Email to a Friend